The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a promising advance. Unlike subcutaneous injections, this technique offers a simpler way to deliver GLP-1 https://reganjpml077461.blogoxo.com/41365103/glp-1-patches-a-novel-approach-to-blood-sugar-control